FDA approves Rinvoq (Upadacitinib) for GCA

Posted by Mike @dadcue, Apr 30 6:46pm

The future of treatment alternatives to Prednisone is looking better and better!
https://www.pharmacytimes.com/view/fda-approves-upadacitinib-for-adult-patients-with-giant-cell-arteritis
-------------------------------
From the manufacture of Rinvoq (Upadacitinib)
https://www.rinvoq.com/giant-cell-arteritis

Interested in more discussions like this? Go to the Polymyalgia Rheumatica (PMR) Support Group.

pmrsuzie | @pmrsuzie | 2 days ago

I have done some reading about Rinvoq unrelated to GCA.
Since the patent for Humira has expired, insurances have been removing it from their formularies forcing some patients to find an alternative. Biosimilars are available for Humira and while Rinvoq is not a biosimilar for Humira, it is an alternative for some patients depending on their medical condition. Humira and Rinvoq are both Abbvie products. Skyrizi is also an Abbvie product.
Rinvoq comes in tablet form so it seems very appealing, no injections, no infusions.
Side effects are always a concern and I was reading patient reviews.